Delivery Order SPE2DR25D1106-SPE2DR26FJB5P
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Eucrisa 2% Ointment in 60-gram quantities, with a ceiling value of $1,688.16. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,956.74 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60gm), with an ultimate completion date of November 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,657.85 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60 grams) on November 5, 2025, with completion targeted for November 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.68 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment (60 grams), a topical medication commonly used for dermatological treatments. This non-competitive delivery order, issued on October 31, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of EUCRISA 2% Ointment in 60-gram units under a firm fixed-price contract with a ceiling value of $4,106.07. The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, to provide a specialty branded pharmaceutical product - Eucrisa 2% Ointment 60GM. The award, valued at $7,349.06, has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,777.97 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Eucrisa 2% ointment, a topical medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The Defense Logistics Agency awarded a $4,275.96 delivery order to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment (60GM) on December 2, 2025, with completion scheduled for December 3, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- The federal contract award is for the delivery of Eucrisa 2% ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,384.68 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,808.20 firm-fixed-price contract is for the supply of EUCRISA 2% ointment, a pharmaceutical product, with an ultimate completion date of August 17, 2023. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. The company is a major supplier of pharmaceutical products and medical supplies to...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB5PDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,222.76 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment in 60-gram units. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with a completion deadline of December 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under the company's broader pharmaceutical supply relationship with DLA. This award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Health Agency's medical supply chain, consistently delivering both brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The competitively awarded delivery order for Eucrisa reflects the company's established capability to meet federal medical procurement requirements and support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/30/25 |